Subchronic toxicity studies with the leukotriene D4 antagonist RG 12525

Area of Science:

• Pharmacology
• Toxicology
• Preclinical Research

Background:

• Leukotriene D4 antagonists are investigated for therapeutic potential.
• Understanding the safety profile of novel drug candidates is crucial.

Purpose of the Study:

• To evaluate the preclinical safety of the leukotriene D4 antagonist RG 12525.
• To assess the effects of repeated oral administration in multiple species.

Main Methods:

• Oral administration of RG 12525 daily for up to 6 months.
• Studies conducted in mice, rats, and monkeys.
• Evaluation of toxicity, organ weights, histopathology, clinical chemistry, and enzyme activities.

Main Results:

• Limited high-dose toxicity observed, with species-specific effects.
• Increased liver weight and hepatocellular hypertrophy in rodents; brown adipose tissue proliferation in rodents.
• Nephrotoxicity in male mice; reversible estrous cycle disruption in female rats.

Conclusions:

• RG 12525 exhibits a manageable safety profile with species-dependent toxicities.
• Further investigation is warranted, particularly regarding rodent-specific findings.
• The drug's effects on liver, adipose tissue, and reproductive cycles require consideration.